tradingkey.logo
搜尋

Xtant Medical Holdings Inc

XTNT
添加自選
0.456USD
-0.014-2.91%
收盤 05/15, 16:00美東報價延遲15分鐘
63.95M總市值
34.64本益比TTM

Xtant Medical Holdings Inc

0.456
-0.014-2.91%

關於 Xtant Medical Holdings Inc 公司

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Inc簡介

公司代碼XTNT
公司名稱Xtant Medical Holdings Inc
上市日期Jun 30, 2010
CEOBrowne (Sean E)
員工數量217
證券類型Ordinary Share
年結日Jun 30
公司地址664 Cruiser Lane
城市BELGRADE
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編59714
電話14063880480
網址https://xtantmedical.com/
公司代碼XTNT
上市日期Jun 30, 2010
CEOBrowne (Sean E)

Xtant Medical Holdings Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
-7.95%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
-20.93%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
-53.11%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
-7.95%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
-20.93%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
-53.11%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Orthobiologics
72.89M
54.43%
Spinal implant
42.31M
31.59%
License revenue
18.72M
13.98%
地區USD
名稱
營收
佔比
United States
122.45M
91.43%
Rest of World
11.48M
8.57%
業務
地區
業務USD
名稱
營收
佔比
Orthobiologics
72.89M
54.43%
Spinal implant
42.31M
31.59%
License revenue
18.72M
13.98%

股東統計

更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
48.83%
Lytton (Laurence W)
5.50%
Vizirgianakis (Stavros G)
4.97%
AWM Investment Company, Inc.
4.71%
Vanguard Capital Management, LLC
1.44%
其他
34.56%
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
48.83%
Lytton (Laurence W)
5.50%
Vizirgianakis (Stavros G)
4.97%
AWM Investment Company, Inc.
4.71%
Vanguard Capital Management, LLC
1.44%
其他
34.56%
股東類型
持股股東
佔比
Hedge Fund
49.89%
Individual Investor
13.86%
Investment Advisor/Hedge Fund
5.61%
Investment Advisor
2.41%
Research Firm
0.03%
其他
28.20%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q4
41
80.10M
114.61%
--
2026Q1
63
83.43M
59.56%
-78.98M
2025Q4
60
79.98M
57.13%
-82.26M
2025Q3
58
80.07M
57.19%
-75.11M
2025Q2
66
93.42M
67.06%
-16.04M
2025Q1
66
107.33M
77.15%
-2.25M
2024Q4
65
107.45M
77.30%
-1.32M
2024Q3
60
109.08M
78.63%
+8.43M
2024Q2
61
99.68M
76.50%
-1.69M
2024Q1
63
100.56M
77.45%
+777.79K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Nantahala Capital Management, LLC
68.39M
48.85%
--
--
Dec 31, 2025
Lytton (Laurence W)
7.70M
5.5%
-1.76M
-18.61%
Dec 31, 2025
Vizirgianakis (Stavros G)
7.52M
5.37%
+553.80K
+7.95%
Nov 15, 2025
AWM Investment Company, Inc.
6.59M
4.71%
--
--
Dec 31, 2025
Browne (Sean E.)
1.94M
1.39%
+394.94K
+25.57%
Nov 15, 2025
Beeson (Jonn R.)
1.53M
1.09%
+158.23K
+11.51%
Nov 15, 2025
Renaissance Technologies LLC
919.86K
0.66%
+205.94K
+28.85%
Dec 31, 2025
Bakewell (John K)
914.12K
0.65%
+158.23K
+20.93%
Nov 15, 2025
Geode Capital Management, L.L.C.
491.95K
0.35%
--
--
Dec 31, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI